409 related articles for article (PubMed ID: 35886945)
21. Toxicity-based toxicokinetic/toxicodynamic assessment of bioaccumulation and nanotoxicity of zerovalent iron nanoparticles in
Yang YF; Lin YJ; Liao CM
Int J Nanomedicine; 2017; 12():4607-4621. PubMed ID: 28721038
[TBL] [Abstract][Full Text] [Related]
22. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
23. Nano-Cell Interactions of Non-Cationic Bionanomaterials.
Ho LWC; Liu Y; Han R; Bai Q; Choi CHJ
Acc Chem Res; 2019 Jun; 52(6):1519-1530. PubMed ID: 31058496
[TBL] [Abstract][Full Text] [Related]
24. Preclinical hazard evaluation strategy for nanomedicines.
Siegrist S; Cörek E; Detampel P; Sandström J; Wick P; Huwyler J
Nanotoxicology; 2019 Feb; 13(1):73-99. PubMed ID: 30182784
[TBL] [Abstract][Full Text] [Related]
25. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.
Hock SC; Ying YM; Wah CL
PDA J Pharm Sci Technol; 2011; 65(2):177-95. PubMed ID: 21502077
[TBL] [Abstract][Full Text] [Related]
26. Nanoparticles: a review of particle toxicology following inhalation exposure.
Bakand S; Hayes A; Dechsakulthorn F
Inhal Toxicol; 2012; 24(2):125-35. PubMed ID: 22260506
[TBL] [Abstract][Full Text] [Related]
27. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
28. Protein corona: Dr. Jekyll and Mr. Hyde of nanomedicine.
Fasoli E
Biotechnol Appl Biochem; 2021 Dec; 68(6):1139-1152. PubMed ID: 33007792
[TBL] [Abstract][Full Text] [Related]
29. The Nanopharmacology and Nanotoxicology of Nanomaterials: New Opportunities and Challenges.
Radomska A; Leszczyszyn J; Radomski MW
Adv Clin Exp Med; 2016; 25(1):151-62. PubMed ID: 26935510
[TBL] [Abstract][Full Text] [Related]
30. New perspectives in nanomedicine.
Thorley AJ; Tetley TD
Pharmacol Ther; 2013 Nov; 140(2):176-85. PubMed ID: 23811125
[TBL] [Abstract][Full Text] [Related]
31. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms.
Lanone S; Boczkowski J
Curr Mol Med; 2006 Sep; 6(6):651-63. PubMed ID: 17022735
[TBL] [Abstract][Full Text] [Related]
32. Safety and Toxicity Implications of Multifunctional Drug Delivery Nanocarriers on Reproductive Systems
Ahmad A
Front Toxicol; 2022; 4():895667. PubMed ID: 35785262
[TBL] [Abstract][Full Text] [Related]
33. Nanotoxicity of Inert Materials: The Case of Gold, Silver and Iron.
Umair M; Javed I; Rehman M; Madni A; Javeed A; Ghafoor A; Ashraf M
J Pharm Pharm Sci; 2016; 19(2):161-80. PubMed ID: 27518167
[TBL] [Abstract][Full Text] [Related]
34. Assessing regulated cell death modalities as an efficient tool for
Tkachenko A; Onishchenko A; Myasoedov V; Yefimova S; Havranek O
Nanotoxicology; 2023 Apr; 17(3):218-248. PubMed ID: 37083543
[TBL] [Abstract][Full Text] [Related]
35. Nano-ophthalmology: Applications and considerations.
Kamaleddin MA
Nanomedicine; 2017 May; 13(4):1459-1472. PubMed ID: 28232288
[TBL] [Abstract][Full Text] [Related]
36. The ecotoxicology of nanoparticles and nanomaterials: current status, knowledge gaps, challenges, and future needs.
Handy RD; Owen R; Valsami-Jones E
Ecotoxicology; 2008 Jul; 17(5):315-25. PubMed ID: 18408994
[TBL] [Abstract][Full Text] [Related]
37. Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function.
Uzhytchak M; Smolková B; Lunova M; Frtús A; Jirsa M; Dejneka A; Lunov O
Adv Drug Deliv Rev; 2023 Jun; 197():114828. PubMed ID: 37075952
[TBL] [Abstract][Full Text] [Related]
38. A Review on Nano-Antimicrobials: Metal Nanoparticles, Methods and Mechanisms.
Hoseinzadeh E; Makhdoumi P; Taha P; Hossini H; Stelling J; Kamal MA; Ashraf GM
Curr Drug Metab; 2017; 18(2):120-128. PubMed ID: 27908256
[TBL] [Abstract][Full Text] [Related]
39. Intracellular uptake, transport, and processing of gold nanostructures.
Chithrani DB
Mol Membr Biol; 2010 Oct; 27(7):299-311. PubMed ID: 20929337
[TBL] [Abstract][Full Text] [Related]
40. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
Son SJ; Bai X; Lee SB
Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
